Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Gain	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		59,921,002
Beginning balance at Dec. 31, 2023	$ 473,576	$ 6	$ 972,973	$ 345	$ (499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)		939,836
Issuance of common stock under benefit plans	3,207		3,207
Stock-based compensation expense	37,626		37,626
Net unrealized loss on short-term investments	(24)			(24)
Net loss	$ (210,304)				(210,304)
Ending balance (in shares) at Dec. 31, 2024	60,860,838	60,860,838
Ending balance at Dec. 31, 2024	$ 304,081	$ 6	1,013,806	321	(710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)		588,452
Issuance of common stock under benefit plans	570		570
Stock-based compensation expense	26,234		26,234
Net unrealized loss on short-term investments	(336)			(336)
Net loss	$ (149,344)				(149,344)
Ending balance (in shares) at Dec. 31, 2025	61,449,290	61,449,290
Ending balance at Dec. 31, 2025	$ 181,205	$ 6	$ 1,040,610	$ (15)	$ (859,396)